EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort

Penelope A Lind iD, Dan J Siskind, Ian B Hickie iD, Lucía Colodro-Conde, Simone Cross, Richard Parker iD, Nicholas G Martin, Sarah E Medland iD

Australian & New Zealand Journal of Psychiatry · 2023-11 · 57 (11) · 1428-1442

DOI: 10.1177/00048674231195571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian & New Zealand Journal of Psychiatry, online erschienen am 01.09.2023. Verfasst von Penelope A Lind und 7 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatric Genetics, Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Bipolar Disorder, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The Australian Genetics of Bipolar Disorder Study is a nation-wide cohort of adults living with bipolar disorder. The study aims to detect the relationships between genetic risk, symptom severity, and the lifetime prevalence of bipolar disorder, treatment response and medication side effects, and patterns and costs of health care usage.

Methods

A total of 6682 participants (68.3% female; aged 44.8 ± 13.6 years [range = 18–90]) were recruited in three waves: a nation-wide media campaign, a mail-out based on prescriptions for lithium carbonate and through the Australian Genetics of Depression Study. Participants completed a self-report questionnaire. A total of 4706 (70%) participants provided a saliva sample and were genotyped and 5506 (82%) consented to record linkage of their Pharmaceutical and Medicare Benefits Schedule data.

Results

Most participants were living with bipolar I disorder ( n = 4068) while 1622 participants were living with bipolar II disorder and 992 with sub-threshold bipolar disorder. The mean age of bipolar disorder diagnosis was 32.7 ± 11.6 years but was younger in bipolar I ( p = 2.0E-26) and females ( p = 5.7E-23). Excluding depression with onset prior to bipolar disorder diagnosis, 64.5% of participants reported one or more co-occurring psychiatric disorders: most commonly generalised anxiety disorder (43.5%) and posttraumatic stress disorder (20.7%). Adverse drug reactions were common and resulted in discontinuation rates ranging from 33.4% for lithium to 63.0% for carbamazepine.

Conclusion

Our findings highlight the high rate of comorbidities and adverse drug reactions among adults living with bipolar disorder in the general Australian population. Future genomic analyses focus on identifying genetic variants influencing pharmacotherapy treatment response and side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderDrug-Related Side Effects and Adverse ReactionsAdultAgedFemaleHumansYoung AdultMaleAustraliaNational Health ProgramsLithium Carbonate

Stichwörter der Autor:innen

AustraliaBipolar disorderadverse drug reactionscomorbidity

Substanzen

Lithium Carbonate

Autor:innen und Institutionen

  • Psychiatric Genetics, Mental Health and Neuroscience Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
  • School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia.
  • Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.
  • Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

ORCID-Profile: Penelope A Lind, Ian B Hickie, Richard Parker, Sarah E Medland

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Lind, P. A., Siskind, D. J., Hickie, I. B., Colodro-Conde, L., Cross, S., Parker, R., Martin, N. G., & Medland, S. E. (2023). Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort. Australian & New Zealand Journal of Psychiatry, 57(11), 1428-1442. https://doi.org/10.1177/00048674231195571

Vancouver

Lind PA, Siskind DJ, Hickie IB, Colodro-Conde L, Cross S, Parker R, et al. Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort. Australian & New Zealand Journal of Psychiatry. 2023;57(11):1428-1442. doi:10.1177/00048674231195571

BibTeX
@article{Lind2023,
  author = {Lind, Penelope A and Siskind, Dan J and Hickie, Ian B and Colodro-Conde, Lucía and Cross, Simone and Parker, Richard and Martin, Nicholas G and Medland, Sarah E},
  title = {Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort},
  journal = {Australian & New Zealand Journal of Psychiatry},
  year = {2023},
  volume = {57},
  number = {11},
  pages = {1428--1442},
  doi = {10.1177/00048674231195571}
}
Kostenlos starten →